Your browser doesn't support javascript.
loading
Phase Ib study of Buparlisib plus Trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on Trastuzumab-based therapy.
Saura, Cristina; Bendell, Johanna; Jerusalem, Guy; Su, Shaun; Ru, Qinhua; De Buck, Stefan; Mills, David; Ruquet, Sophie; Bosch, Ana; Urruticoechea, Ander; Beck, Joseph T; Di Tomaso, Emmanuelle; Sternberg, David W; Massacesi, Cristian; Hirawat, Samit; Dirix, Luc; Baselga, Jose.
Afiliação
  • Saura C; Authors' Affiliations: Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Catalan Institute of Oncology, Barcelona, Spain; Sarah Cannon Research Institute, Nashville, Tennessee; Novartis Pharmaceuticals, East Hanover, NJ; Novartis Pharmaceuticals, Florham Park, New Jersy; C.H.U. Sart-Tilman, Liege; Oncologisch Centrum AZ-St. Augustinus Oncology, Antwerp, Belgium; Novartis Pharma AG, Basel, Switzerland; Novartis Oncology,
Clin Cancer Res ; 20(7): 1935-45, 2014 Apr 01.
Article em En | MEDLINE | ID: mdl-24470511
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Inibidores de Fosfoinositídeo-3 Quinase Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Inibidores de Fosfoinositídeo-3 Quinase Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article